Mesoblast Ltd (ASX:MSB)
Pharmaceuticals, Biotechnology & Life Sciences
Mesoblast Ltd (ASX:MSB) is a leader in providing allogeneic (off the shelf) cellular medicines. It owns a portfolio of late-stage product candidates with three product candidates in Phase 3 trials, being acute graft versus host disease, chronic heart failure and chronic low back pain due to degenerative disc disease. The company has facilities in Melbourne, New York, Singapore and Texas and is listed on the ASX and the NASDAQ.
Mesoblast Ltd (ASX:MSB) share price
Mesoblast Ltd (ASX:MSB) share price news
ASX Bank Shares
S&P/ASX 200 dips on healthcare, Mesoblast tanks on FDA queries
S&P/ASX 200 (ASX:XJO) managed a 0.2% gain on Friday, overcoming weakness in healthcare. Karoon Energy Ltd (ASX:KAR) share price rose 4.2%.
August 7, 2023
Today's ASX news
ASX 200 morning report – WOW, MSB & KGN shares in focus
The S&P/ASX 200 (ASX: XJO) finished broadly flat on Tuesday as Woolworths (ASX:WOW) and Mesoblast (ASX:MSB) shares were in the news.
December 15, 2021
Healthcare ASX shares
Here’s why the Mesoblast (ASX:MSB) share price is getting smashed
The Mesoblast Limited (ASX:MSB) share price is being crunched. It’s down 16% after giving an update about its Novartis (SWX:NOVN) agreement.
December 14, 2021
Today's ASX news
ASX 200 morning report – MFG, TLS & WPL shares in focus
The S&P/ASX 200 (ASX:XJO) continued its positive run on Wednesday as Magellan (ASX:MFG) and Telstra (ASX:TLS) shares made headlines.
December 9, 2021
Today's ASX news
ASX 200 morning report – WPL, ELD & TLS shares in focus
The S&P/ASX 200 (ASX: XJO) gained another 0.3% to begin the week as Woodside (ASX:WPL) and Telstra (ASX:TLS) shares made headlines.
November 16, 2021
ASX Growth Shares
Why the Mesoblast (ASX:MSB) share price is down 21% this week
Shares in Mesoblast Limited (ASX: MSB) have taken a 21% dive this week following the release of its FY21 results. Here are the details.
September 2, 2021
Healthcare ASX shares
Why the Mesoblast (ASX:MSB) share price is under the spotlight
The Mesoblast Limited (ASX:MSB) share price is under the spotlight right now on its FY21 fourth quarter.
July 30, 2021
ASX Growth Shares
Will Mesoblast (ASX:MSB) shares rise on news of a new drug?
Mesoblast Limited (ASX: MSB) shares have had a horrid twelve months, falling by 40%. Can this new lower back pain drug lift Mesoblast shares?
July 1, 2021
Today's ASX news
ASX 200 morning report – BLD, SVW & CHC shares in focus
The S&P/ASX 200 (ASX: XJO) delivered another strong day on Friday. Boral (ASX:BLD) and Seven (ASX:SVW) shares are making headlines.
June 28, 2021